ByTrending Posts
Is McRae Tech Setting a New Standard for…
McRae Tech has introduced Orchestral, a health-focused AI orchestrator data platform designed to support large-scale, governed use of…
Is Sanofi Strengthening Its Adult Vaccine Strategy with…
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by announcing a $2.2…
Has Sanofi’s Dupixent Been Approved for Pediatric Asthma…
Tokyo, Japan – December 23, 2025 Sanofi and Regeneron have received regulatory approval in Japan for Dupixent (dupilumab)…
Will Novartis’ $280M Gene Therapy Plant Transform Denton…
Denton, TX The Denton City Council has unanimously approved an economic development agreement with Novartis Gene Therapies, paving…
Will Novo Nordisk Pull Ahead of Eli Lilly…
The U.S. Food and Drug Administration (FDA) has approved the first daily oral version of the obesity drug…
Is Tanya Alcorn Poised to Transform Pfizer’s Global…
Pfizer has appointed Tanya Alcorn as President, Global Hospital and Biosimilars, expanding her leadership responsibilities after serving more…
Is Pfizer Facing New Safety Scrutiny After Reporting…
Pfizer has disclosed that a patient enrolled in a clinical trial evaluating its investigational hemophilia treatment Hympavzi died…
How Is Pfizer Expanding Its Oncology Pipeline Through…
Cambridge, Massachusetts Pfizer is strengthening its oncology research pipeline through a new program launched under its strategic collaboration…
Will AI-Powered Prior Authorization Change How Medicare Care…
December 2025 — Medicare is preparing to introduce artificial intelligence–driven prior authorization reviews for certain medical services beginning…
Trending Posts
Latest Stories
Roche Doubles Down on U.S. Biomanufacturing: $2 Billion Investment to Advance Next-Generation Therapies
23 January 2026 Executive Summary Roche’s Genentech unit announced a major expansion of its biomanufacturing…
Can Johnson & Johnson’s $550 Million Vision Care Expansion Drive Local Growth and Innovation?
23 January 2026 Executive Summary Johnson & Johnson’s Vision Care division is advancing a major…
Can Johnson & Johnson Hit $100 Billion in Revenue Despite U.S. Pricing Pressures?
23 January 2026 Executive Summary Johnson & Johnson (J&J) has issued a bullish 2026 revenue…
Can AI-Driven Chemistry Partnerships Like Merck–ChemLex Accelerate Drug Discovery?
23 January 2026 Executive Summary Merck has signed a Memorandum of Understanding (MoU) with ChemLex,…
Gallery
